TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/26 16:44 | 7/7/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 10 | S.m | -55,675 | 45.08 | 0 | -1,235 | 3,597 | I | |||||||||||||||
6/24/26 19:19 | 6/22/26 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | S | -51,683 | 45.28 | 0 | -1,142 | 7,389 | I | |||||||||||||||
4/9/26 17:38 | 4/7/26 | ACET | Adicet Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | S.m | -675 | 6.45 | 0 | -105 | 923 | I | |||||||||||||||
10/27/25 17:19 | 10/23/25 | PMVP | Pmv Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | S | -2,420 | 1.61 | 0 | -1,500 | 5,975 | I | |||||||||||||||
7/1/25 21:23 | 6/27/25 | CRVS | Corvus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | S.d | -4,892 | 4.16 | 0 | -1,176 | 7,165 | I | |||||||||||||||
6/26/25 17:10 | 6/24/25 | PASG | Passage Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | S.m | -197 | 0.3379 | 0 | -584 | 6,066 | I | |||||||||||||||
5/16/25 17:26 | 5/14/25 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | 1 | 1 | S | -2,665 | 15.85 | 0 | -168 | 3,238 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |